{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:03:10Z","timestamp":1790996590168,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neuroscience.2024.11.056","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T22:35:26Z","timestamp":1733438126000},"page":"312-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Risk factors and predictive models in the progression from MCI to Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"565","author":[{"given":"Chang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shike","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuroscience.2024.11.056_b0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11065-017-9361-5","article-title":"Consortium for the early identification of Alzheimer's d-Q. neuropsychological measures that predict progression from mild cognitive impairment to Alzheimer's type dementia in older adults: a systematic review and meta-analysis","volume":"27","author":"Belleville","year":"2017","journal-title":"Neuropsychol. Rev."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.11.056_b0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jamaneurol.2020.0414","article-title":"Association of Klotho-VS heterozygosity with risk of Alzheimer disease in individuals who carry APOE4","volume":"77","author":"Belloy","year":"2020","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.11.056_b0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.11.056_b0020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.trci.2019.05.010","article-title":"Rates of lobar atrophy in asymptomatic MAPT mutation carriers","volume":"5","author":"Chen","year":"2019","journal-title":"Alzheimer's & Dementia (new York, N y)."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40035-020-00201-6","article-title":"The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline","volume":"9","author":"Chen","year":"2020","journal-title":"Trans. Neurodegen."},{"key":"10.1016\/j.neuroscience.2024.11.056_b0030","article-title":"Optimal structure identification with greedy search","author":"Chickering","year":"2003","journal-title":"J. Mach. Learn. Res."},{"issue":"Pt 12","key":"10.1016\/j.neuroscience.2024.11.056_b0035","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/brain\/awn278","article-title":"Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study","volume":"131","author":"de Jong","year":"2008","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.056_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.667899","article-title":"The effects of CSF neurogranin and APOE \u03b54 on cognition and neuropathology in mild cognitive impairment and Alzheimer's disease","volume":"13","author":"Fan","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2024.11.056_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2024.11.056_b0050","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fneur.2019.00904","article-title":"Identification of the early stage of Alzheimer's disease using structural MRI and resting-state fMRI","volume":"10","author":"Hojjati","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003860","article-title":"Protection against discrimination in national dementia guideline recommendations: a systematic review","volume":"19","author":"James","year":"2022","journal-title":"PLoS Med."},{"issue":"14","key":"10.1016\/j.neuroscience.2024.11.056_b0060","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202000675","article-title":"Generalizable reproducible, and neuroscientifically interpretable imaging biomarkers for Alzheimer's disease","volume":"7","author":"Jin","year":"2020","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40478-021-01220-8","article-title":"Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature","volume":"9","author":"Kahriman","year":"2021","journal-title":"Acta Neuropathologica Commun."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-018-0462-z","article-title":"Data-driven prognostic features of cognitive trajectories in patients with amnestic mild cognitive impairments","volume":"11","author":"Kim","year":"2019","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.11.056_b0075","first-page":"1","article-title":"Dementia mortality in the United States, 2000-2017 national vital statistics reports: from the centers for disease control and prevention, national center for health statistics","volume":"68","author":"Kramarow","year":"2019","journal-title":"Natl. Vital Stat. Syst.."},{"issue":"23","key":"10.1016\/j.neuroscience.2024.11.056_b0080","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.2014.13806","article-title":"The diagnosis and management of mild cognitive impairment: a clinical review","volume":"312","author":"Langa","year":"2014","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.11.056_b0085","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.7150\/thno.68439","article-title":"Dysfunction of striatal MeCP2 is associated with cognitive decline in a mouse model of Alzheimer's disease","volume":"12","author":"Lee","year":"2022","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0090","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/s41598-018-37769-z","article-title":"Predicting Alzheimer's disease progression using multi-modal deep learning approach","volume":"9","author":"Lee","year":"2019","journal-title":"Scientif. Rep."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.11.056_b0095","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2017.11.004","article-title":"A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data","volume":"14","author":"Li","year":"2018","journal-title":"Alzheimer's Dementia: Journal Alzheimer's Assoc."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0100","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-021-24672-x","article-title":"Ion mobility-based sterolomics reveals spatially and temporally distinctive sterol lipids in the mouse brain","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-022-00516-0","article-title":"Selective reduction of astrocyte apoE3 and apoE4 strongly reduces A\u03b2 accumulation and plaque-related pathology in a mouse model of amyloidosis","volume":"17","author":"Mahan","year":"2022","journal-title":"Mol. Neurodegen."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0110","article-title":"Molecular insight into the therapeutic promise of targeting APOE4 for Alzheimer\u2019s disease","volume":"2020","author":"Mamun","year":"2020","journal-title":"Oxidative Med. Cell. Longevity"},{"issue":"4","key":"10.1016\/j.neuroscience.2024.11.056_b0115","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1212\/WNL.0000000000200573","article-title":"Neuropathologic features of antemortem atrophy-based subtypes of Alzheimer disease","volume":"99","author":"Mohanty","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2024.11.056_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines10010169","article-title":"Diagnostic blood biomarkers in Alzheimer's Disease","volume":"10","author":"Park","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/brain\/awy289","article-title":"Apolipoprotein E4 genotype compromises brain exosome production","volume":"142","author":"Peng","year":"2019","journal-title":"Brain A J. Neurol.."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.11.056_b0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s41060-016-0032-z","article-title":"A million variables and more: the Fast Greedy Equivalence Search algorithm for learning high-dimensional graphical causal models, with an application to functional magnetic resonance images","volume":"3","author":"Ramsey","year":"2017","journal-title":"Int. J. Data Sci. Anal."},{"issue":"10043","key":"10.1016\/j.neuroscience.2024.11.056_b0135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2024.11.056_b0140","article-title":"An end-to-end library for causal inference","author":"Sharma","year":"2020","journal-title":"Papers."},{"key":"10.1016\/j.neuroscience.2024.11.056_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103077","article-title":"Causal structure discovery identifies risk factors and early brain markers related to evolution of white matter hyperintensities","volume":"35","author":"Shen","year":"2022","journal-title":"Neuroimage Clin."},{"issue":"12","key":"10.1016\/j.neuroscience.2024.11.056_b0150","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid beta 1\u201342 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.11.056_b0160","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/jmri.27689","article-title":"Individualized prediction of early Alzheimer's disease based on magnetic resonance imaging radiomics, clinical, and laboratory examinations: a 60-month follow-up study","volume":"54","author":"Tang","year":"2021","journal-title":"J. Magnetic Resonance Imaging"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.11.056_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020411","article-title":"Delivery of intravenously administered antibodies targeting Alzheimer's disease-relevant tau species into the brain based on receptor-mediated transcytosis","volume":"14","author":"Tashima","year":"2022","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroimage.2007.07.008","article-title":"Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment","volume":"38","author":"Teipel","year":"2007","journal-title":"Neuroimage."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.11.056_b0175","article-title":"Triglyceride-glucose index, Alzheimer's disease plasma biomarkers, and dementia in older adults: the MIND-China study","volume":"15","author":"Tian","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.11.056_b0180","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jamaneurol.2017.0244","article-title":"Evaluation of amyloid protective factors and Alzheimer disease neurodegeneration protective factors in elderly individuals","volume":"74","author":"Vemuri","year":"2017","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.11.056_b0185","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","article-title":"Evaluation of Tau imaging in staging Alzheimer disease and revealing interactions between \u03b2-amyloid and Tauopathy","volume":"73","author":"Wang","year":"2016","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.11.056_b0190","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12929-022-00799-x","article-title":"The pathogenic effects of particulate matter on neurodegeneration: a review","volume":"29","author":"You","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0200","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","article-title":"Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference","volume":"9","author":"Young","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.056_b0205","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","article-title":"APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224006444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224006444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T01:42:34Z","timestamp":1736214154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224006444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"alternative-id":["S0306452224006444"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.11.056","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and predictive models in the progression from MCI to Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.11.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}